Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Visceral Pain | 9 | 2024 | 20 | 2.860 |
Why?
|
| Irritable Bowel Syndrome | 6 | 2024 | 32 | 1.590 |
Why?
|
| Gastrointestinal Tract | 6 | 2020 | 35 | 1.590 |
Why?
|
| Colon | 9 | 2024 | 123 | 1.380 |
Why?
|
| Optogenetics | 2 | 2020 | 8 | 1.210 |
Why?
|
| Gastrointestinal Diseases | 4 | 2019 | 55 | 1.200 |
Why?
|
| Nociception | 3 | 2015 | 51 | 1.160 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 1508 | 0.960 |
Why?
|
| Amygdala | 3 | 2017 | 52 | 0.900 |
Why?
|
| Gastrointestinal Motility | 6 | 2018 | 30 | 0.890 |
Why?
|
| Enteric Nervous System | 4 | 2020 | 10 | 0.850 |
Why?
|
| Corticosterone | 3 | 2015 | 35 | 0.840 |
Why?
|
| Stress, Psychological | 5 | 2024 | 233 | 0.700 |
Why?
|
| Neurology | 1 | 2020 | 11 | 0.660 |
Why?
|
| Gastroenterology | 1 | 2020 | 15 | 0.660 |
Why?
|
| Animals | 25 | 2025 | 10705 | 0.630 |
Why?
|
| Abdominal Pain | 1 | 2017 | 35 | 0.540 |
Why?
|
| Brain | 5 | 2024 | 770 | 0.510 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2015 | 18 | 0.470 |
Why?
|
| Pain | 3 | 2015 | 258 | 0.460 |
Why?
|
| Central Amygdaloid Nucleus | 1 | 2015 | 6 | 0.450 |
Why?
|
| Liver Diseases | 1 | 2015 | 52 | 0.440 |
Why?
|
| Chronic Pain | 2 | 2018 | 62 | 0.430 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2024 | 554 | 0.400 |
Why?
|
| Rats | 11 | 2024 | 1590 | 0.380 |
Why?
|
| Bifidobacterium | 1 | 2011 | 3 | 0.350 |
Why?
|
| Probiotics | 1 | 2011 | 19 | 0.340 |
Why?
|
| Rats, Inbred F344 | 4 | 2017 | 174 | 0.340 |
Why?
|
| Colitis | 3 | 2024 | 54 | 0.330 |
Why?
|
| Neural Pathways | 2 | 2020 | 122 | 0.290 |
Why?
|
| Intestinal Mucosa | 3 | 2018 | 198 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2018 | 20 | 0.290 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2019 | 138 | 0.240 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2025 | 9 | 0.240 |
Why?
|
| Male | 14 | 2024 | 13946 | 0.230 |
Why?
|
| Oligodendroglia | 1 | 2024 | 17 | 0.220 |
Why?
|
| Myelin Sheath | 1 | 2024 | 28 | 0.220 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 16 | 0.220 |
Why?
|
| Humans | 13 | 2025 | 28906 | 0.220 |
Why?
|
| Signal Transduction | 2 | 2025 | 1469 | 0.170 |
Why?
|
| Pressure | 2 | 2017 | 90 | 0.150 |
Why?
|
| Estrogens | 1 | 2019 | 56 | 0.150 |
Why?
|
| Cholinergic Neurons | 1 | 2018 | 5 | 0.150 |
Why?
|
| Ion Transport | 1 | 2018 | 11 | 0.150 |
Why?
|
| Analgesics | 2 | 2024 | 38 | 0.140 |
Why?
|
| Spinal Cord | 3 | 2024 | 214 | 0.140 |
Why?
|
| Channelrhodopsins | 1 | 2017 | 1 | 0.140 |
Why?
|
| Halorhodopsins | 1 | 2017 | 1 | 0.140 |
Why?
|
| GABAergic Neurons | 1 | 2017 | 3 | 0.140 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 5 | 0.140 |
Why?
|
| Consciousness | 1 | 2017 | 6 | 0.140 |
Why?
|
| Neural Inhibition | 1 | 2017 | 48 | 0.140 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 27 | 0.140 |
Why?
|
| Adenoviridae | 1 | 2017 | 68 | 0.130 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2015 | 4 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2017 | 118 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 166 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 148 | 0.130 |
Why?
|
| Neoplasms | 1 | 2025 | 874 | 0.120 |
Why?
|
| Therapies, Investigational | 1 | 2015 | 1 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2016 | 108 | 0.110 |
Why?
|
| Mineralocorticoids | 1 | 2015 | 1 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2015 | 4 | 0.110 |
Why?
|
| Physical Stimulation | 1 | 2015 | 72 | 0.110 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 21 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 130 | 0.110 |
Why?
|
| Nociceptors | 1 | 2014 | 42 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2015 | 391 | 0.110 |
Why?
|
| Electric Stimulation Therapy | 2 | 2005 | 58 | 0.100 |
Why?
|
| Cholesterol | 1 | 2015 | 203 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 121 | 0.100 |
Why?
|
| Receptors, Serotonin, 5-HT4 | 1 | 2012 | 4 | 0.090 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2012 | 3 | 0.090 |
Why?
|
| Pain Measurement | 2 | 2003 | 172 | 0.090 |
Why?
|
| Hyperalgesia | 1 | 2012 | 16 | 0.090 |
Why?
|
| Mutation | 2 | 2025 | 867 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 3 | 2024 | 14 | 0.090 |
Why?
|
| Drug Implants | 1 | 2010 | 14 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 634 | 0.080 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2006 | 10 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2006 | 28 | 0.060 |
Why?
|
| Mice | 3 | 2024 | 4809 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 843 | 0.060 |
Why?
|
| Defecation | 2 | 2018 | 11 | 0.060 |
Why?
|
| Genes, Mitochondrial | 1 | 2024 | 10 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2024 | 13 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 25 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 44 | 0.050 |
Why?
|
| Pain Management | 1 | 2005 | 66 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2024 | 62 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 513 | 0.050 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2003 | 2 | 0.050 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2003 | 2 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2024 | 585 | 0.050 |
Why?
|
| Rectum | 1 | 2003 | 50 | 0.050 |
Why?
|
| A549 Cells | 1 | 2018 | 17 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2018 | 35 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 2018 | 6 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2018 | 8 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 2018 | 8 | 0.040 |
Why?
|
| Guinea Pigs | 2 | 2012 | 73 | 0.030 |
Why?
|
| Gastric Juice | 1 | 2017 | 4 | 0.030 |
Why?
|
| Intestinal Secretions | 1 | 2017 | 2 | 0.030 |
Why?
|
| Gastrointestinal Absorption | 1 | 2017 | 4 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 236 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1351 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 218 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 1259 | 0.030 |
Why?
|
| Time Factors | 2 | 2010 | 1615 | 0.030 |
Why?
|
| Visceral Afferents | 2 | 2003 | 12 | 0.020 |
Why?
|
| Enterochromaffin Cells | 1 | 2012 | 1 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2012 | 4 | 0.020 |
Why?
|
| Chlorides | 1 | 2012 | 13 | 0.020 |
Why?
|
| Serotonin | 1 | 2012 | 16 | 0.020 |
Why?
|
| Goblet Cells | 1 | 2012 | 15 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2012 | 65 | 0.020 |
Why?
|
| Mucus | 1 | 2012 | 13 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 101 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 190 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 328 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 278 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2012 | 89 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 465 | 0.020 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2010 | 4 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 155 | 0.020 |
Why?
|
| Feces | 1 | 2010 | 117 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 249 | 0.020 |
Why?
|
| Autoradiography | 1 | 2006 | 29 | 0.020 |
Why?
|
| Peroxidase | 1 | 2006 | 39 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 50 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 70 | 0.010 |
Why?
|
| Reflex | 1 | 2005 | 74 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 451 | 0.010 |
Why?
|
| Naphthyridines | 1 | 2003 | 4 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2003 | 41 | 0.010 |
Why?
|
| Female | 1 | 2018 | 15649 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 612 | 0.010 |
Why?
|
| Inflammation | 1 | 2005 | 668 | 0.010 |
Why?
|